As COVID-19 continues to mutate and circulate worldwide, research into the potential role of hyperbaric therapy has been gaining momentum. Although many studies are still underway, we are gaining increasing insight into how hyperbaric therapy may help some patients avoid ventilation, address lung inflammation caused by the virus, and even alleviate the long-term chronic effects commonly referred to as “Long Hauler’s Syndrome.”
Many of our clients seeking relief from Long Hauler’s symptoms—such as fatigue, brain fog, and moderate to severe pain—have reported noticeable improvements after starting hyperbaric therapy.